An interventional study of Brief Dialectical Behavior Therapy-Skills Training and Relaxation in Suicide Ideation, Coping Skills and Emotion Regulation, sponsored by Muhammed Ali Boztepe. Withdrawn at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-08.
Sponsored by Muhammed Ali Boztepe · Not applicable, Interventional, and Prevention
The goal of this clinical trial is to learn if Brief Dialectical Behavior Therapy Skills Training (DBT-BST) can prevent suicidality in adults. The main questions it aims to answer are:
Researchers will compare DBT-BST to relaxation to see if DBT-BST works to reduce suicidal ideation.
Participants will:
225 studies on the registry are indexed under Emotional Regulation; 122 are open to participants now.
Browse Emotional Regulation studies →This is the only study on the registry with Muhammed Ali Boztepe as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Behavioral: Brief Dialectical Behavior Therapy-Skills Training
Behavioral: Relaxation
The intervention is administered in a single session, lasting approximately 60 minutes and conducted in person. It is important to note that there are no ongoing sessions. In the intervention, participants are provided with 5 basic skills of Dialectical Behavior Therapy: 1) mindfulness, 2) mindfulness of current emotions, 3) opposite-to-emotion action, 4) distraction, and 5) changing body chemistry. These strategies are grouped under 3 categories: 1) Mindfulness, 2) Emotion regulation (mindfulness of current emotions, opposite-to-emotion action), 3) Tolerating distress (distraction, changing body chemistry). These skills are not designed to treat or solve the crisis. The main aim is to provide effective coping mechanisms that can be implemented quickly before the crisis escelates, to help overcome the intense emotional pain and keep the person alive.
The control group will be subjected to a relaxation exercise, with the objective of managing participant expectations, researcher attention/interest, and time spent, as well as providing a coping strategy for stress.
Change from Baseline in the Suicidality at 1 Month as Assessed by Suicide Probability Scale
36 is equivalent to the lowest suicidality, and 144 indicates the highest suicidality.
Time frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Change from Baseline in the Suicidal Cognitions at 1 Month as Assessed by Suicide Cognitions Scale
18 is equivalent to the lowest suicidal cognitions, and 90 indicates the highest suicidal cognitions.
Time frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Change from Baseline in the Hopelessness at 1 Month as Assessed by Beck Hopelessness Scale
Zero is equivalent to the lowest hopelessness, and 20 indicates the highest hopelessness.
Time frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Change from Baseline in the Emotion Regulation Skills at 1 Month as Assessed by Emotion Regulation Skills Questionnaire
Zero is equivalent to the lowest emotion regulation skills, and 108 indicates the highest skills.
Time frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Change from Baseline in the Difficulties in Emotion Regulation at 1 Month as Assessed by Difficulties in Emotion Regulation Scale-16
16 is equivalent to the lowest difficulties, and 80 indicates the highest difficulties in emotion regulation.
Time frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Change from Baseline in the Depression, Anxiety, and Stress at 1 Month as Assessed by Depression Anxiety Stress Scale-21 (DASS-21)
Higher points are equivalent to higher symptoms as assessed by the related subscale of DASS-21. Each subscale ranges from 0 to 28.
Time frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Plan to share: Undecided
No publications or documents are linked to this record.
This study is withdrawn, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.